‘Exciting’ siRNA Therapy for Hypertension Passes First Hurdle
Patients with hypertension successfully dialed down their angiotensinogen levels and had lasting reductions in blood pressure (BP) following one injection of an investigational small interfering RNA (siRNA) therapy, according to a phase I study. In this first-in-human, placebo-controlled study, patients who received zilebesiran showed dose-dependent decreases in serum angiotensinogen levels and 24-hour ambulatory BP after […]
Quiz Time: How Much Do You Know About Women in Medicine?
Throughout history, women have made a lasting impact on healthcare. As Women’s History Month winds down, take this quick quiz to test your knowledge of these crucial members of the medical community. Please enable JavaScript to view the comments powered by Disqus.